Julia E.McEvoy (Julie)

Partner

(T) + 1.202.879.3867 (F) + 1.202.626.1700

With more than 20 years experience at Jones Day and as a senior Department of Justice official, Julie McEvoy is a trusted advisor in antitrust and litigation matters involving private litigants as well as government agencies.

Julie defends clients against civil claims arising from the alleged misuse of patents, regulatory processes, and private pricing agreements. She obtained a complete defense verdict for Sanofi on charges it filed a sham "citizen petition" with FDA to suppress competition for Arava and is currently defending Sanofi against antitrust and RICO claims concerning the prices of its insulin products.

Julie has extensive experience in criminal antitrust matters, conducting and resolving investigations and defending follow-on civil litigation. After criminal investigations of the vitamins industry, Julie acted as national coordinating counsel for defendants in hundreds of state cases and played similar roles in automobile and paper industry cases.

Julie also represents clients in merger matters, including the FTC's challenge to the proposed combination of the Penn State Hershey Medical Center with Pinnacle Health Systems.

During the Obama Administration, Julie served as Deputy Associate Attorney General, counseled DOJ principals on significant matters, and led various inter-agency initiatives. She oversaw the Antitrust Division and participated in formulating policies and strategies for investigating, litigating, and resolving civil and criminal antitrust cases. Julie also advised Administration officials on immigration issues; directed the President's Task Force on Puerto Rico; and spearheaded legislative, policy, and social justice projects.

Julie has a vibrant pro bono practice, assisting asylum seekers from around the world.

Experience

  • PinnacleHealth System and Penn State Hershey attempt to merge Pennsylvania hospitalsJones Day represented PinnacleHealth System and Penn State Milton S. Hershey Medical Center as antitrust counsel in the hospitals' proposed merger.
  • Yazaki defends against automotive wire harness antitrust class actionsJones Day represents Yazaki North America and Yazaki Corporation in connection with numerous antitrust class action complaints alleging that Yazaki and other auto parts manufacturers violated the Sherman Act by engaging in bid-rigging and price-fixing in sales of automotive wire harnesses and related products.
  • sanofi-aventis wins unanimous jury verdict in Arava antitrust litigationJones Day defended sanofi-aventis in an antitrust jury trial involving the claims of a class of drug wholesalers that sanofi had unlawfully blocked generic competition for its rheumatoid arthritis drug Arava.
  • Aventis Pharmaceuticals successfully defends against monopolization claims based on fraud on the Patent Office theoryJones Day resolved class action claims that Aventis Pharmaceuticals, the exclusive licensee of patents covering DDAVP (a treatment for certain water metabolism disorders), knew that the licensor obtained those patents by fraud before the Patent and Trademark Office.
  • UPM-Kymmene defends against pressure-sensitive labelstock antitrust class action litigationOn behalf of UPM-Kymmene and its subsidiary, Raflatac, Jones Day serves as global coordinating and trial counsel in connection with multiple federal and state cases brought as class actions and alleging price fixing and market allocation surrounding the sale of pressure-sensitive labelstock.
  • European pharmaceutical manufacturer resolves EC and DOJ investigations of methylglucamine producersJones Day coordinated the defense of a European life-sciences company in various criminal and regulatory investigations concerning alleged price-fixing and market allocation activities with respect to methylglucamine, an ionic chemical compound added to x-ray contrast media to enhance soft-tissue images.
  • Aventis resolves numerous federal and state cases around the U.S. involving antitrust issues in the vitamins industryJones Day represented Aventis (now known as sanofi-aventis) with respect to more than 150 civil antitrust cases filed in federal and state courts around the U.S.
  • Washington Group International prevails in Hurricane Katrina mass tort actionJones Day successfully defended Washington Group International, Inc. ("WGI," now URS Energy & Construction Company, a subsidiary of URS Corp.) in a mass tort action alleging that WGI's work on behalf of the U.S. Army Corps of Engineers contributed to floodwall breaches in New Orleans during Hurricane Katrina.
  • President's right to indefinitely detain a U.S. civilian in military custody is challengedJones Day contributed to a major constitutional decision when Washington office partners Timothy J. Finn and Julia E. McEvoy and associate Katherine E. Stern filed an amicus brief on behalf of the National Association of Criminal Defense Lawyers in Al-Marri v. Wright, the first case to test whether the President may seize a U.S. resident civilian and hold him indefinitely in military custody without due process or other constitutional protections.
  • Speaking Engagements

    • December 3, 2013
      A Civil Action: The Civil Implications of a Criminal Investigation, Jones Day CLE Academy 2013
    • July 22, 2009
      Jury Instructions in Civil Antitrust Litigation, ABA Teleseminar
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.